Can Medicaid Rate Improvements Drive Elevance's 2027 Margin Recovery?
Elevance Health Targets 12% Earnings Growth in 2027 as Insurance Margins Recover
Elevance Health (ELV) Stock Looks Reasonable After Raised Earnings Outlook
Elevance Health (ELV) In Focus On AM Best Rating Action And A Fair Value Debate
AM Best Assigns Indicative Issue Credit Ratings to Elevance Health, Inc.’s New Shelf Registration
ELV or RVTY: Which Is the Better Value Stock Right Now?
An $11 Billion Fund Is Betting Big on Elevance Health
What Needs To Be True To Buy Elevance Health Stock?
Elevance Health (ELV) Is Up 2.73% in One Week: What You Should Know
Elevance Health Files Prospectus For Mixed Shelf Offering; Terms Not Disclosed
Molina Healthcare (MOH) vs. ELV and UNH: Can Margin Recovery and Acquisitions Unlock Long-Term Upside?
Wells Fargo Maintains Overweight on Elevance Health, Raises Price Target to $492
Implied Volatility Surging for Elevance Health Stock Options
ELV vs. RVTY: Which Stock Is the Better Value Option?
TD Cowen Maintains Buy on Elevance Health, Raises Price Target to $495
Elevance Health (ELV) Stock Rallies As Q3 Results Tighten Margin Focus
UBS Maintains Buy on Elevance Health, Raises Price Target to $523
Guggenheim Maintains Buy on Elevance Health, Raises Price Target to $485
Morgan Stanley Maintains Equal-Weight on Elevance Health, Raises Price Target to $449
RBC Capital Maintains Sector Perform on Elevance Health, Raises Price Target to $455
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.